216 related articles for article (PubMed ID: 8606382)
1. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer.
Kundu N; Beaty TL; Jackson MJ; Fulton AM
J Natl Cancer Inst; 1996 Apr; 88(8):536-41. PubMed ID: 8606382
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis.
Kundu N; Fulton AM
Cell Immunol; 1997 Aug; 180(1):55-61. PubMed ID: 9316639
[TBL] [Abstract][Full Text] [Related]
3. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Zheng LM; Ojcius DM; Garaud F; Roth C; Maxwell E; Li Z; Rong H; Chen J; Wang XY; Catino JJ; King I
J Exp Med; 1996 Aug; 184(2):579-84. PubMed ID: 8760811
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and antimetastatic activity of IL-23.
Lo CH; Lee SC; Wu PY; Pan WY; Su J; Cheng CW; Roffler SR; Chiang BL; Lee CN; Wu CW; Tao MH
J Immunol; 2003 Jul; 171(2):600-7. PubMed ID: 12847224
[TBL] [Abstract][Full Text] [Related]
6. Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12.
Popovic D; El-Shami KM; Vadai E; Feldman M; Tzehoval E; Eisenbach L
Clin Exp Metastasis; 1998 Oct; 16(7):623-32. PubMed ID: 9932609
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide.
Kundu N; Dorsey R; Jackson MJ; Guiterrez P; Wilson K; Fu S; Ramanujam K; Thomas E; Fulton AM
Int J Cancer; 1998 May; 76(5):713-9. PubMed ID: 9610731
[TBL] [Abstract][Full Text] [Related]
8. Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cells.
Alosco T; Croy BA; Gansbacher B; Wang HQ; Rao U; Bankert R
Cancer Immunol Immunother; 1993 Jun; 36(6):364-72. PubMed ID: 8500109
[TBL] [Abstract][Full Text] [Related]
9. Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody.
Rakhmilevich AL; Hooper AT; Hicklin DJ; Sondel PM
Mol Cancer Ther; 2004 Aug; 3(8):969-76. PubMed ID: 15299079
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of glycosylated recombinant human lymphotoxin for growth inhibition of human and murine solid tumors and experimental metastasis in mice.
Funahashi I; Kawatsu M; Kajikawa T; Takeo K; Asahi T; Kakutani T; Yamashita T; Kawaharada H; Watanabe K
J Immunother (1991); 1991 Feb; 10(1):28-38. PubMed ID: 2012798
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
[TBL] [Abstract][Full Text] [Related]
13. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines.
Cayeux S; Beck C; Aicher A; Dörken B; Blankenstein T
Eur J Immunol; 1995 Aug; 25(8):2325-31. PubMed ID: 7545119
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells.
Tasaki K; Yoshida Y; Maeda T; Miyauchi M; Kawamura K; Takenaga K; Yamamoto H; Kouzu T; Asano T; Ochiai T; Sakiyama S; Tagawa M
Cancer Gene Ther; 2000 Feb; 7(2):247-54. PubMed ID: 10770633
[TBL] [Abstract][Full Text] [Related]
16. Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts.
Tasaki K; Yoshida Y; Miyauchi M; Maeda T; Takenaga K; Kouzu T; Asano T; Ochiai T; Sakiyamna S; Tagawa M
Cancer Gene Ther; 2000 Feb; 7(2):255-61. PubMed ID: 10770634
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts.
Ishiguro H; Kishimoto T; Furuya M; Nagai Y; Watanabe T; Ishikura H
Cancer Immunol Immunother; 2005 Dec; 54(12):1191-9. PubMed ID: 15846489
[TBL] [Abstract][Full Text] [Related]
18. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Hafner M; Falk W; Echtenacher B; Männel DN
Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
[TBL] [Abstract][Full Text] [Related]
20. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
